Using COVID-19 Vaccine AstraZeneca in Community Pharmacy

Amanda Cooper, Associate Director, Medicines Use and Safety (SPS)Published Last updated See all updates

Requirements specific to the AstraZeneca vaccine when used for the COVID-19 vaccination service within community pharmacy settings

Authorisation for use

The MHRA’s conditions of authorisation and the information for healthcare professionals and recipients outlines the framework through which the vaccine can be used.

Storing vaccine appropriately

Effective process control is essential to ensure that vaccines are stored correctly and expiry dates and times are allocated.

Up to date information on storage ​requirements may be found in the product specific documentation.

Preparing vaccine

Using COVID-19 Vaccine AstraZeneca in Community Pharmacy

Requirements specific to the AstraZeneca vaccine when used for the COVID-19 vaccination service within community pharmacy settings

Administration

Administration requires diligent process control to ensure the vaccine is safe and effective at the point of use.

Use in relation to prior allergy

Prior to administration, prior allergy status should be checked.

Advising individuals with allergies on their suitability for COVID-19 Vaccine AstraZeneca

Advice on whether people with a previous allergic reaction can have the COVID-19 Vaccine AstraZeneca.

Process flow for vaccination session

A diagram giving an overview of the process during a vaccination session is attached below.

SOPs, work instructions and checklists to adapt

Relevant Standard Operating Procedures, work instructions and checklists are available below. These may be adapted by Superintendent Pharmacists for use in Community Pharmacy settings.

Receiving and storing Vaxzevria Vaccine at PCN designated sites

31 December 2020Standard Operating Procedure for PCN designated sites receiving and storing the Vaxzevria Vaccine.

Preparing the Vaxzevria Vaccine at PCN designated sites and end user locations

7 January 2021Standard Operating Procedure for preparation of Vaxzevria Vaccine in PCN designated sites and end user locations prior to immediate administration.

Stocktaking and reconciliation of the Vaxzevria Vaccine at PCN designated sites

31 December 2020Standard Operating Procedure for the stocktaking and reconciliation of the Vaxzevria Vaccine at PCN designated sites.

Disposing of the Vaxzevria Vaccine at PCN designated sites

31 December 2020Standard Operating Procedure for safe disposal of damaged, used, or expired Vaxvezria Vaccine consigned for destruction at PCN Designated Sites.

Dealing with spillages and breakages of the Vaxzevria Vaccine at PCN designated sites

31 December 2020Dealing with spillages and breakages of the Vaxzevria Vaccine at PCN designated sites

Transporting the Vaxzevria Vaccine from PCN designated sites to end user locations, patients’ homes and within the PCN Grouping

6 January 2021SOP for transporting the Vaxzevria Vaccine from PCN designated sites to end user locations, patients’ homes and within the PCN Grouping.

Change history

  1. Simplification of storage requirements. Removal of reference to additional doses within vials. All other current content is still accurate.
  1. The current content is still accurate
  1. Removal of "temporary" in conditions of authorisation. All other current content is still accurate.
  1. Published